• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于联合癌症治疗的含形状各向异性纳米颗粒的pH敏感磁性脂质体的研发

Development of pH-Sensitive Magnetoliposomes Containing Shape Anisotropic Nanoparticles for Potential Application in Combined Cancer Therapy.

作者信息

Pacheco Ana Rita F, Cardoso Beatriz D, Pires Ana, Pereira André M, Araújo João P, Carvalho Violeta M, Rodrigues Raquel O, Coutinho Paulo J G, Castelo-Grande Teresa, Augusto Paulo A, Barbosa Domingos, Lima Rui A, Teixeira Senhorinha F C F, Rodrigues Ana Rita O, Castanheira Elisabete M S

机构信息

Physics Centre of Minho and Porto Universities (CF-UM-UP), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.

Associate Laboratory LaPMET, 4710-057 Braga, Portugal.

出版信息

Nanomaterials (Basel). 2023 Mar 15;13(6):1051. doi: 10.3390/nano13061051.

DOI:10.3390/nano13061051
PMID:36985945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10054438/
Abstract

Late diagnosis and systemic toxicity associated with conventional treatments make oncological therapy significantly difficult. In this context, nanomedicine emerges as a new approach in the prevention, diagnosis and treatment of cancer. In this work, pH-sensitive solid magnetoliposomes (SMLs) were developed for controlled release of the chemotherapeutic drug doxorubicin (DOX). Shape anisotropic magnetic nanoparticles of magnesium ferrite with partial substitution by calcium (MgCaFeO) were synthesized, with and without calcination, and their structural, morphological and magnetic properties were investigated. Their superparamagnetic properties were evaluated and heating capabilities proven, either by exposure to an alternating magnetic field (AMF) (magnetic hyperthermia) or by irradiation with near-infrared (NIR) light (photothermia). The MgCaFeO calcined nanoparticles were selected to integrate the SMLs, surrounded by a lipid bilayer of DOPE:Ch:CHEMS (45:45:10). DOX was encapsulated in the nanosystems with an efficiency above 98%. DOX release assays showed a much more efficient release of the drug at pH = 5 compared to the release kinetics at physiological pH. By subjecting tumor cells to DOX-loaded SMLs, cell viability was significantly reduced, confirming that they can release the encapsulated drug. These results point to the development of efficient pH-sensitive nanocarriers, suitable for a synergistic action in cancer therapy with magnetic targeting, stimulus-controlled drug delivery and dual hyperthermia (magnetic and plasmonic) therapy.

摘要

传统治疗方法所带来的诊断延迟和全身毒性使得肿瘤治疗极具难度。在此背景下,纳米医学作为癌症预防、诊断和治疗的一种新方法应运而生。在本研究中,开发了pH敏感型固体磁脂质体(SMLs)用于化疗药物阿霉素(DOX)的控释。合成了部分被钙取代的镁铁氧体形状各向异性磁性纳米颗粒(MgCaFeO),有煅烧和未煅烧两种情况,并对其结构、形态和磁性进行了研究。通过暴露于交变磁场(AMF)(磁热疗)或近红外(NIR)光照射(光热疗)评估了它们的超顺磁性特性并证明了其加热能力。选择煅烧后的MgCaFeO纳米颗粒来构建SMLs,其被DOPE:Ch:CHEMS(45:45:10)的脂质双层包围。DOX被封装在纳米系统中,封装效率高于98%。DOX释放试验表明,与生理pH下的释放动力学相比,在pH = 5时药物释放效率更高。通过将肿瘤细胞暴露于负载DOX的SMLs中,细胞活力显著降低,证实它们能够释放封装的药物。这些结果表明开发出了高效的pH敏感型纳米载体,适用于在癌症治疗中通过磁靶向、刺激控制药物递送和双热疗(磁热疗和等离子体热疗)发挥协同作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dfd/10054438/d6f347d19139/nanomaterials-13-01051-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dfd/10054438/6fddd65e2490/nanomaterials-13-01051-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dfd/10054438/a096878d26e1/nanomaterials-13-01051-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dfd/10054438/5cacd28e2b94/nanomaterials-13-01051-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dfd/10054438/f28c9634ac36/nanomaterials-13-01051-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dfd/10054438/d6f347d19139/nanomaterials-13-01051-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dfd/10054438/6fddd65e2490/nanomaterials-13-01051-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dfd/10054438/a096878d26e1/nanomaterials-13-01051-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dfd/10054438/5cacd28e2b94/nanomaterials-13-01051-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dfd/10054438/f28c9634ac36/nanomaterials-13-01051-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dfd/10054438/d6f347d19139/nanomaterials-13-01051-g007.jpg

相似文献

1
Development of pH-Sensitive Magnetoliposomes Containing Shape Anisotropic Nanoparticles for Potential Application in Combined Cancer Therapy.用于联合癌症治疗的含形状各向异性纳米颗粒的pH敏感磁性脂质体的研发
Nanomaterials (Basel). 2023 Mar 15;13(6):1051. doi: 10.3390/nano13061051.
2
Magnetoliposomes Based on Shape Anisotropic Calcium/Magnesium Ferrite Nanoparticles as Nanocarriers for Doxorubicin.基于形状各向异性钙/镁铁氧体纳米颗粒的磁脂质体作为阿霉素的纳米载体
Pharmaceutics. 2021 Aug 12;13(8):1248. doi: 10.3390/pharmaceutics13081248.
3
Magnetoliposomes with Calcium-Doped Magnesium Ferrites Anchored in the Lipid Surface for Enhanced DOX Release.脂质表面锚定钙掺杂镁铁氧体的磁脂质体用于增强阿霉素释放
Nanomaterials (Basel). 2023 Sep 20;13(18):2597. doi: 10.3390/nano13182597.
4
Solid Magnetoliposomes as Multi-Stimuli-Responsive Systems for Controlled Release of Doxorubicin: Assessment of Lipid Formulations.固体磁脂质体作为阿霉素控释的多刺激响应系统:脂质制剂评估
Biomedicines. 2022 May 23;10(5):1207. doi: 10.3390/biomedicines10051207.
5
Magnetoliposomes containing magnesium ferrite nanoparticles as nanocarriers for the model drug curcumin.含有镁铁氧体纳米颗粒的磁性脂质体作为模型药物姜黄素的纳米载体。
R Soc Open Sci. 2018 Oct 17;5(10):181017. doi: 10.1098/rsos.181017. eCollection 2018 Oct.
6
Stealth Magnetoliposomes Based on Calcium-Substituted Magnesium Ferrite Nanoparticles for Curcumin Transport and Release.基于钙取代的镁铁氧体纳米粒子的隐形磁脂体用于姜黄素的传递和释放。
Int J Mol Sci. 2020 May 21;21(10):3641. doi: 10.3390/ijms21103641.
7
Light/magnetic hyperthermia triggered drug released from multi-functional thermo-sensitive magnetoliposomes for precise cancer synergetic theranostics.多功能温敏磁脂体介导的磁/光热疗触发药物释放用于精确癌症协同治疗。
J Control Release. 2018 Feb 28;272:145-158. doi: 10.1016/j.jconrel.2017.04.028. Epub 2017 Apr 23.
8
Elastic Liposomes Containing Calcium/Magnesium Ferrite Nanoparticles Coupled with Gold Nanorods for Application in Photothermal Therapy.含有钙/镁铁氧体纳米颗粒与金纳米棒耦合的弹性脂质体在光热疗法中的应用
Nanomaterials (Basel). 2024 Apr 15;14(8):679. doi: 10.3390/nano14080679.
9
Magnetoliposomes Based on Magnetic/Plasmonic Nanoparticles Loaded with Tricyclic Lactones for Combined Cancer Therapy.基于负载三环内酯的磁性/等离子体纳米颗粒的磁脂质体用于联合癌症治疗
Pharmaceutics. 2021 Nov 10;13(11):1905. doi: 10.3390/pharmaceutics13111905.
10
Investigation of magnetic silica with thermoresponsive chitosan coating for drug controlled release and magnetic hyperthermia application.磁性二氧化硅载热敏性壳聚糖用于药物控释和磁热疗的研究。
Mater Sci Eng C Mater Biol Appl. 2019 Apr;97:23-30. doi: 10.1016/j.msec.2018.11.076. Epub 2018 Nov 30.

引用本文的文献

1
Lipid Nanoparticle Delivery System for Normalization of Tumor Microenvironment and Tumor Vascular Structure.用于肿瘤微环境和肿瘤血管结构正常化的脂质纳米颗粒递送系统。
Biomater Res. 2025 Feb 11;29:0144. doi: 10.34133/bmr.0144. eCollection 2025.
2
Economic and Accessible Portable Homemade Magnetic Hyperthermia System: Influence of the Shape, Characteristics and Type of Nanoparticles in Its Effectiveness.经济实惠且便于携带的自制磁热疗系统:纳米颗粒的形状、特性和类型对其有效性的影响
Materials (Basel). 2024 May 11;17(10):2279. doi: 10.3390/ma17102279.
3
Elastic Liposomes Containing Calcium/Magnesium Ferrite Nanoparticles Coupled with Gold Nanorods for Application in Photothermal Therapy.

本文引用的文献

1
Self-assembled hydrogel nanocube for stimuli responsive drug delivery and tumor ablation by phototherapy against breast cancer.自组装水凝胶纳米立方体制备刺激响应型药物递送系统,并通过光疗治疗乳腺癌引发肿瘤消融。
Int J Biol Macromol. 2022 Jul 31;213:435-446. doi: 10.1016/j.ijbiomac.2022.05.190. Epub 2022 Jun 1.
2
Development of Thermo- and pH-Sensitive Liposomal Magnetic Carriers for New Potential Antitumor Thienopyridine Derivatives.用于新型潜在抗肿瘤噻吩并吡啶衍生物的热和pH敏感脂质体磁性载体的研发
Materials (Basel). 2022 Feb 25;15(5):1737. doi: 10.3390/ma15051737.
3
Magnetoliposomes Based on Shape Anisotropic Calcium/Magnesium Ferrite Nanoparticles as Nanocarriers for Doxorubicin.
含有钙/镁铁氧体纳米颗粒与金纳米棒耦合的弹性脂质体在光热疗法中的应用
Nanomaterials (Basel). 2024 Apr 15;14(8):679. doi: 10.3390/nano14080679.
4
Magnetoliposomes with Calcium-Doped Magnesium Ferrites Anchored in the Lipid Surface for Enhanced DOX Release.脂质表面锚定钙掺杂镁铁氧体的磁脂质体用于增强阿霉素释放
Nanomaterials (Basel). 2023 Sep 20;13(18):2597. doi: 10.3390/nano13182597.
5
Bovine Lactoferrin-Loaded Plasmonic Magnetoliposomes for Antifungal Therapeutic Applications.用于抗真菌治疗应用的载牛乳铁蛋白的等离子体磁脂质体
Pharmaceutics. 2023 Aug 19;15(8):2162. doi: 10.3390/pharmaceutics15082162.
基于形状各向异性钙/镁铁氧体纳米颗粒的磁脂质体作为阿霉素的纳米载体
Pharmaceutics. 2021 Aug 12;13(8):1248. doi: 10.3390/pharmaceutics13081248.
4
PEG-PEI-modified gated N-doped mesoporous carbon nanospheres for pH/NIR light-triggered drug release and cancer phototherapy.PEG-PEI 修饰的门控 N 掺杂介孔碳纳米球用于 pH/NIR 光触发药物释放和癌症光疗。
J Mater Chem B. 2021 May 5;9(17):3666-3676. doi: 10.1039/d1tb00362c.
5
Facet-dependent gold nanocrystals for effective photothermal killing of bacteria.基于晶面各向异性的金纳米晶体用于高效光热杀菌。
J Hazard Mater. 2021 Apr 5;407:124617. doi: 10.1016/j.jhazmat.2020.124617. Epub 2020 Dec 9.
6
Stealth Magnetoliposomes Based on Calcium-Substituted Magnesium Ferrite Nanoparticles for Curcumin Transport and Release.基于钙取代的镁铁氧体纳米粒子的隐形磁脂体用于姜黄素的传递和释放。
Int J Mol Sci. 2020 May 21;21(10):3641. doi: 10.3390/ijms21103641.
7
Shape Anisotropic Iron Oxide-Based Magnetic Nanoparticles: Synthesis and Biomedical Applications.形状各向异性氧化铁基磁性纳米粒子:合成与生物医学应用。
Int J Mol Sci. 2020 Apr 1;21(7):2455. doi: 10.3390/ijms21072455.
8
Self-assembly of Organic Nanomaterials and Biomaterials: The Bottom-Up Approach for Functional Nanostructures Formation and Advanced Applications.有机纳米材料与生物材料的自组装:形成功能性纳米结构及先进应用的自下而上方法。
Materials (Basel). 2020 Feb 26;13(5):1048. doi: 10.3390/ma13051048.
9
Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release.用于控制释放的温敏和 pH 敏感脂质体的最新进展。
J Control Release. 2019 Dec 10;315:1-22. doi: 10.1016/j.jconrel.2019.09.018. Epub 2019 Oct 21.
10
Magnetoliposomes Containing Calcium Ferrite Nanoparticles for Applications in Breast Cancer Therapy.含铁酸钙纳米颗粒的磁性脂质体在乳腺癌治疗中的应用
Pharmaceutics. 2019 Sep 14;11(9):477. doi: 10.3390/pharmaceutics11090477.